META-ANALYSIS OF PATIENTS (PTS) PREVIOUSLY TREATED WITH TAXANES FROM THREE RANDOMIZED TRIALS OF BEVACIZUMAB (BV) AND FIRST-LINE CHEMOTHERAPY AS TREATMENT FOR METASTATIC BREAST CANCER (MBC)

被引：0
|
作者：
Miles, D. W. [1 ]
Romieu, G. [2 ]
Dieras, V. [3 ]
Chen, D. [4 ]
Duenne, A. [5 ]
O'Shaughnessy, J. [6 ]
机构：
[1] Mt Vernon Canc Ctr, London, England
[2] CRLC Val Aurelle, Montpellier, France
[3] Inst Curie, Paris, France
[4] Genentech Inc, San Francisco, CA 94080 USA
[5] F Hoffmann La Roche Ltd, Basel, Switzerland
[6] Baylor Sammons Canc Ctr, Dallas, TX USA
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [1] META-ANALYSIS OF PATIENTS (PTS) ≥65 YEARS FROM THREE RANDOMIZED TRIALS OF BEVACIZUMAB (BV) AND FIRST-LINE CHEMOTHERAPY AS TREATMENT FOR METASTATIC BREAST CANCER (MBC)
    Miles, D. W.
    Romieu, G.
    Dieras, V.
    Chen, D.
    Duenne, A.
    Robert, N.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 97 - 97
  • [2] A meta-analysis of overall survival data from three randomized trials of bevacizumab (BV) and first-line chemotherapy as treatment for patients with metastatic breast cancer (MBC)
    O'Shaughnessy, J.
    Miles, D.
    Gray, R. J.
    Dieras, V.
    Perez, E. A.
    Zon, R.
    Cortes, J.
    Zhou, X.
    Phan, S.
    Miller, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Meta-Analysis of Patients with Triple-Negative Breast Cancer (TNBC) from Three Randomized Trials of First-Line Bevacizumab (BV) and Chemotherapy Treatment for Metastatic Breast Cancer (MBC)
    O'Shaughnessy, J.
    Romieu, G.
    Dieras, V.
    Byrtek, M.
    Duenne, A-A
    Miles, D.
    [J]. CANCER RESEARCH, 2010, 70
  • [4] Bevacizumab in combination with taxanes for the first-line treatment of metastatic breast cancer
    Chan, A.
    Miles, D. W.
    Pivot, X.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 (12) : 2305 - 2315
  • [5] Bevacizumab in combination with first-line chemotherapy in patients with metastatic colorectal cancer: a meta-analysis
    Hu, W.
    Xu, W. -S.
    Liao, X. -F.
    He, H. -J.
    [J]. MINERVA CHIRURGICA, 2015, 70 (06) : 451 - 458
  • [6] Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
    Loupakis, Fotios
    Bria, Emilio
    Vaccaro, Vanja
    Cuppone, Federica
    Milella, Michele
    Carlini, Paolo
    Cremolini, Chiara
    Salvatore, Lisa
    Falcone, Alfredo
    Muti, Paola
    Sperduti, Isabella
    Giannarelli, Diana
    Cognetti, Francesco
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2010, 29
  • [7] Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
    Fotios Loupakis
    Emilio Bria
    Vanja Vaccaro
    Federica Cuppone
    Michele Milella
    Paolo Carlini
    Chiara Cremolini
    Lisa Salvatore
    Alfredo Falcone
    Paola Muti
    Isabella Sperduti
    Diana Giannarelli
    Francesco Cognetti
    [J]. Journal of Experimental & Clinical Cancer Research, 29
  • [8] Efficacy of capecitabine (C)-based therapy in patients with first-line metastatic breast cancer (MBC) previously treated with adjuvant anthracyclines and taxanes
    Siedentopf, F.
    Schoenegg, W.
    Kaufmann, M.
    Debled, M.
    Robert, N. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Docetaxel and bevacizumab with or without trastuzumab as first-line treatment for patients with metastatic breast cancer: a meta-analysis
    Sun, Z-W
    Lan, X-Y
    Kong, F-L
    Gao, Y-Y
    Li, S.
    Xi, Y-L
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (17) : 5365 - 5373
  • [10] Bevacizumab (BV) maintenance (M) after first-line chemotherapy (CT) plus BV for metastatic colorectal cancer (mCRC) patients (pts): A meta-analysis of individual pts data (IPD) from three phase III studies.
    Salvatore, Lisa
    Bria, Emilio
    Sperduti, Isabella
    Hinke, Axel
    Hegewisch-Becker, Susanna
    Aparicio, Thomas
    Le Malicot, Karine
    Boige, Valerie
    Koeberle, Dieter
    Baertschi, Daniela
    Dietrich, Daniel
    Tortora, Giampaolo
    Arnold, Dirk
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345